ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 71 filers reported holding ALLOVIR INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,347,796 | -26.1% | 1,091,998 | +16.9% | 0.00% | – |
| Q2 2023 | $3,175,484 | -9.0% | 933,966 | +5.5% | 0.00% | – |
| Q1 2023 | $3,489,288 | -61.3% | 885,606 | -49.7% | 0.00% | – |
| Q4 2022 | $9,027,898 | +30.4% | 1,759,824 | +100.5% | 0.00% | – |
| Q3 2022 | $6,923,000 | +146.5% | 877,501 | +21.8% | 0.00% | – |
| Q2 2022 | $2,809,000 | -27.6% | 720,201 | +25.2% | 0.00% | – |
| Q1 2022 | $3,882,000 | -75.5% | 575,179 | -53.0% | 0.00% | -100.0% |
| Q4 2021 | $15,827,000 | -48.1% | 1,223,095 | +0.6% | 0.00% | -50.0% |
| Q3 2021 | $30,469,000 | -9.8% | 1,215,836 | -29.0% | 0.00% | 0.0% |
| Q2 2021 | $33,786,000 | -7.7% | 1,711,571 | +9.4% | 0.00% | 0.0% |
| Q1 2021 | $36,605,000 | +26.2% | 1,564,335 | +107.3% | 0.00% | 0.0% |
| Q4 2020 | $29,011,000 | +321.9% | 754,702 | +201.8% | 0.00% | – |
| Q3 2020 | $6,876,000 | – | 250,052 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $44,004,000 | 1.88% |
| GMT CAPITAL CORP | 2,758,846 | $21,767,000 | 1.35% |
| Regency Capital Management Inc.\DE | 75,010 | $592,000 | 0.73% |
| Redmile Group, LLC | 1,907,969 | $15,054,000 | 0.58% |
| Samsara BioCapital, LLC | 82,336 | $650,000 | 0.15% |
| Alkeon Capital Management | 4,923,104 | $38,843,000 | 0.13% |
| Woodline Partners LP | 1,087,093 | $8,577,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,625 | $612,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 44,987 | $355,000 | 0.07% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,634 | $9,023,000 | 0.07% |